Group items tagged

The Department of Industrial Policy and Promotion (DIPP) has released a statistic affirming Foreign Direct Investment in the region of pharmaceuticals and drugs. The value of investments will be around US $ 8.81 billion that comes to about Rs 48,828.3 crore in Indian currency. It is predicted that, the biotechnology industry will surpass 11.6 billion dollars by the year 2017

Course "Validation and 21 CFR 11 Compliance of Computer Systems: Intermediate to Advanced" has been pre-approved by RAPS as eligible for up to 12 credits towards a participant's RAC recertification upon full completion. Overview: Computer Systems Validation (CSV) also known as Software Validation is all-pervasive in the Life Sciences Industry. It is a requirement of all the predicate rules, as well as 21 CFR 11 and Annex 11. However, unless one knows how to implement CSV, it is often very hard to detect the requirement for CSV, and very hard to determine what needs to be done, to meet domestic and / or international regulations or business continuity requirements. In addition, the FDA has stepped up 21 CFR 11 inspections that include CSV. This course will build on the Validation and 21 CFR 11 Compliance Basic Course, to give hands on experience on executing on the computer systems validation of a system, and to discuss related activities such as Validation Master Plan, Infrastructure Qualification, Project Management for Validation and Validation of Test Tools The attendees must have attended the Basic Validation & 21 CFR 11 Compliance. This is a very hands-on class and the attendees will be expected to use templates provided in the class to create the complete package for the validation of a system The Seminar: This Hands-On course will provide the attendees with more detailed experience on validation / 21 CFR 11 compliance of a computer system, as well as details for activities associated with computer systems validation as follows: 1. Validation Master Plan 2. Complete Validation for a System 3. Excel Spreadsheet Validation 4. Change Control 5. SOPs 6. Test Tools Validation 7. Project Management for Validation Who Should Attend : * VP of IT * Director of IT * Quality Managers * Project Managers (for CSV / IT) * Validation Specialists * Database Administrators * System Administrators * Directors / Senior Directors of Discovery * Directors /

Course "Validation and 21 CFR 11 Compliance of Computer Systems: Intermediate to Advanced" has been pre-approved by RAPS as eligible for up to 12 credits towards a participant's RAC recertification upon full completion. Overview: Computer Systems Validation (CSV) also known as Software Validation is all-pervasive in the Life Sciences Industry. It is a requirement of all the predicate rules, as well as 21 CFR 11 and Annex 11. However, unless one knows how to implement CSV, it is often very hard to detect the requirement for CSV, and very hard to determine what needs to be done, to meet domestic and / or international regulations or business continuity requirements. In addition, the FDA has stepped up 21 CFR 11 inspections that include CSV. This course will build on the Validation and 21 CFR 11 Compliance Basic Course, to give hands on experience on executing on the computer systems validation of a system, and to discuss related activities such as Validation Master Plan, Infrastructure Qualification, Project Management for Validation and Validation of Test Tools The attendees must have attended the Basic Validation & 21 CFR 11 Compliance. This is a very hands-on class and the attendees will be expected to use templates provided in the class to create the complete package for the validation of a system The Seminar: This Hands-On course will provide the attendees with more detailed experience on validation / 21 CFR 11 compliance of a computer system, as well as details for activities associated with computer systems validation as follows: 1. Validation Master Plan 2. Complete Validation for a System 3. Excel Spreadsheet Validation 4. Change Control 5. SOPs 6. Test Tools Validation 7. Project Management for Validation Who Should Attend: * VP of IT * Director of IT * Quality Managers * Project Managers (for CSV / IT) * Validation Specialists * Database Administrators * System Administrators * Directors / Senior Directors of Discovery * Directors / Senior

GlaxoSmithKline Pharmaceuticals Ltd is investing Rs 1,000 crore in a new state-of-the-art pharmaceutical unit in Karnataka ...

With more than a 100,000 practitioners in this discipline; medical coding is catching up as a viable profession for many in the US and away. Medical coding is emerging as a completely specialized profession in the healthcare sector. This is how the core of their professional work needs to be understood: Uses of medical coding On the face of it, medical coding is used for filing healthcare claims, but the usefulness of this profession goes beyond this. The data churned out by medical coding helps healthcare professionals make more accurate diagnosis and help in enhanced treatment protocols. Ensuring accuracy in medical coding is crucial to administering proper healthcare. Medical coding not only ensures a systematic and standardized manner in which third parties claim payment; the critical data that medical coding generates can be harnessed for further use The information contained in medical coding data in the form of medical codes is a precise indicator of a patient's health history. This information, when refined, helps actuaries take decisions on making investments for their business By feeding policy makers and public health departments with important information on the incidence of diseases, medical coding also fosters proper allocation of resources to the particular segment of the healthcare industry about the kind of services that the community requires at a given point of time. This leads to an improved outlook for the general health of the patient population and reduces wastage of fund allocation. Learn more on this topic by visiting : http://bit.ly/23ajt0v

Overview: The presentation takes the participant through the steps needed to ensure a successful health care computer system implementation. Once presented the participant will see the logic of the tools and processes and be able to apply them to their system implementation. The tools and processes presented in this material have been developed by implementing health care systems for over 40 years and seeing what has worked and WHY it has worked. These tools and processes have been equally and successfully applied to the implementation of large, complex systems and smaller, simpler systems for large, multidepartment organizations and for small health care organizations. The process focuses on establishing the project's implementation expectations, identifying meaningful metrics for success, establishing project plans, assigning individual accountabilities and responsibilities, establishing and executing project tasks, monitoring project progress and validating project success. To establish viable project expectations, the presentation addresses the need for bringing all of the stakeholders (organization owners, providers and management, operations staff, IT staff and the vendor) into establishing common and realizable expectations. These are reviewed in context of the organization's current environment and its short and long term goals and are considered as a critical part of the implementation completion process. In the case of turning around an already troubled or failed system implementation, the process emphasizes the tasks of reassessing the project stakeholder expectations - why they decided the system would help the organization and what they expected to get from the system. Next the process shows the participant how to convert these expectations to realistic and measurable project success metrics. The process focuses on learning how to separate "so what" metrics from meaningful and measurable metrics. In addition, the process provides direction regardin

Through a comparative analysis on the development of biopharmaceuticals mfg. industry in 31 provincial regions and 20 major cities in visualized form of data map, the report provides key data and concise analyses on the biopharmaceuticals mfg. industry in China, a list of major 20 enterprises in the sector as well as the comparison on investment environment in top 10 hot regions. In addition, the report truly reflects the position of foreign enterprises in biopharmaceuticals mfg. industry across China based on a comprehensive comparison of operating conditions among different enterprise types.

Whether you wear glasses as a backup when your eyes need a break from your contacts or they're your go-to vision aid, you know that between the frames and the lenses, eyeglasses are an investment.

When movement is impaired by injury or a chronic health condition, a transport wheelchair can help regain some of the mobility. The traditional or standard weight transport wheelchair has two large rear wheels and a pair of smaller wheels in the front. Advances in design and materials have made different models available to suit different needs. Lightweight transport wheelchairs made of light but sturdy aluminum are a good choice for more active individuals, as well as for people who take frequent trips from home. when the wheelchair will need to be folded and more easily lifted and stowed in a car trunk. A transport chair solves limited mobility issues without the need to use a traditional wheelchair that is heavy and hard to collapse and put in a car. A transport chair typically has four small wheels, two in the front and two in the rear. Lightweight wheelchairs are effortlessly carried up and down stairs due to their ultra light nature and portability, making them the perfect choice for those who do not require a wheelchair at all times. The chair can be simply folded and stored until required. Travelling by car, coach or plane is made simple and the practicality of a wheelchair that is easily manoeuvred and stored makes everyday life uncomplicated and stress free. Choosing the right wheelchair that meets every personal requirement is an important decision for all wheelchair users. They offer a wealth of benefits as well as a wheelchair that is durable and adaptable, with numerous opportunities to be personalised to meet each individual need. Lightweight transport wheelchair mobility chairs feature adjustable frames, which allow to change the angle of the seat back to achieve several different seating positions. Lightweight wheelchairs with desk-length armrests enable users to sit closer to a table or desk; while, full-length armrests provide complete support of the arms. Karma KM 2500 L Big Wheel Wheelchair: Karma KM 2500 L Wheelchair Specifications:

A transport wheelchair is a mobility chair designed for convenience, short-distance use and easy handling by a caregiver. Lightweight and foldable, these wheelchairs are easily moved and typically fit in the trunk of most vehicles. There is even a model designed to fold into a bag to be carried over the shoulder. Transport Chair is designed to create a welcoming and safe environment that speaks volumes to caregivers, patients and their family members. Obvious touchpoints help make operation intuitive for all users. BackSmart ergonomics have been incorporated into the design to reduce the bending and reaching associated with caregiver injury. A rigid frame helps enhance durability while reducing the risk of theft. This investment in the well-being of patients and caregivers tells them care about their comfort and safety. Transport wheel chairs are practical for errands and trips to the store or the doctor. Hospitals sometimes utilize these flexible mobility chairs to move patients around their facilities. Karma KM 2500 L Big Wheel Wheelchair: Karma KM 2500 L Wheelchair Specifications: Width 18" Front/Rear Wheels 6" to 22" Seat Width 47cm Seat Depth 40cm Overall Width 66cm Overall Collapsed Width 36cm Armrest Height 21cm Overall Length 90cm Seat Height 47cm Backrest Height 38cm Overall Height 86cm Weight 11.kg Karma KM 2500 L Wheelchair Seat and Back: AEGIS Microbe Shield Approved by the FDA, EPA, EU, etc., bonded anti-microbial barrier upholstery protects from odor, staining and deterioration from bacteria, fungus and other microorganisms. It is a shield for your health. Karma KM 2500 L Wheelchair Extended Armrest By simulating the natural position of arms, the extended armrest design is ergonomic and creates bigger seating space. An Ultra lightweight wheelchair (11 kg) with a compact design for either attendant assisted or self propelling users. The use of aircraft-grade aluminium alloy and double cross brace provide this

Overview: Safe hospital care in neither a science nor an art. It is a practice just like the practice by a doctor who combines hindsight of experience and foresight of imagination to come up with an outsight of the best interventions and best protocols. Over time the doctor standardizes the process but is vigilant to any unique requirements of each patient. Such an approach in patient safety is called hazard analysis and mitigation process. This webinar goes a big step farther. It covers innovation strategies to assure that the safety improvements result in a high return on investment and high value to the hospital, and protects the patients. Why should you Attend: About 400,000 patients die each year from hospital mistakes according to a senate hearing. Evidence based methods to reduce adverse, sentinel, and never events are available and successful in aerospace, nuclear, and chemical industries. Why not use them? We need a paradigm shift. We need it in a hurry! You cannot cross the sea merely by standing and staring at the water. Do not be afraid to take a big step if one is indicated. No noble thing can be done without risks Areas Covered in the Session: The Etiologies of Unsafe Care Sufficient Understanding is a Pre-requisite to Safe Care Preventing "Indifferencity" to Enhance Patient Safety Continuous innovation is better than Continuous Improvement Innovations Should Start with Incidence Reports Hazard Analysis Fault Tree Analysis-the Best Tool for Harm Prevention Doing More with Less is Innovation Re-Invent Quality Management Human Errors may be Unpreventable, Preventing Harm is an Innovation Managing Safety: Lessons from Aerospace Protect Patients from Dangers in Medical Devices The Paradigm Pioneers Aequanimitas,The Best Known Strategy for Safe Care Who Will Benefit: Hospital senior management Hospital administrators Doctors Nursing staff Clinical engineers Radiology staff Infection control staff Patient advocates Speaker Profile Dev Raheja

How To Prevent Diabetes Type 2? You have just discovered that you are prediabetic. You can take meaningful steps to reduce your risk of diabetes. You can actually prevent diabetes simply by changing what you eat and how you invest in your physical health. The ball, my friend, is still in your court.

Around 8.3 percent population in the US has diabetes. Type II is the most prevalent form of diabetes. It is common among the young and the obese. Diabetes Mellitus or simply diabetes is a group of metabolic disorders characterized by an increase in your blood sugar. This results from an inadequate amount of insulin in the body or the cells' inability to respond to insulin.

High potency active pharmaceutical ingredients are molecules widely used in the production of hormonal drugs which are used for the treatment of breast cancer. It is also used in the central nervous system drugs, cardiovascular drugs, and musculoskeletal drugs. Moreover, recently they have been also gaining demand in the gynecology & cosmetics industry. These drugs are segmented into innovative and generic. The growing prevalence of cancer is predominantly fueling the growth of the high potency active pharmaceutical ingredients market. The increasing number of the pharmaceutical industry coupled with the growing investment in the research and development activities conducted by the pharmaceutical industry is again contributing to the market growth. Moreover, increasing use of high potency active pharmaceutical ingredients as antibody-drug conjugates as it is one of the most important and effective treatments for cancer is also projected to augment the market growth. It is also used to treat glaucoma which is further anticipated to foster the growth of the high potency active pharmaceutical ingredients market. From the geographical point of view, North America is expected to gain significant growth over the forecast period and this is attributed to the high prevalence of chronic disease in the region. Read more @ https://sachinbhombe.blogspot.com/2021/03/high-potency-active-pharmaceutical.html

The digital genome consists of a complete digital collection of DNA material that occurs within an organism or a cell. It's a simpler method to collect genetic data concerning hereditary disorders and is used extensively by geneticists for a closer look at potential genetic illnesses. It was first intended to be a tool of diagnosis but has evolved into a powerful research tool. The growing popularity of the human genome projects is a prime factor fueling the growth of the digital genome market. According to Forbes, by 2025, it's projected that 100 million genomes will be sequenced. Increasing funding for genomics is another major factor in augmenting market growth. Moreover, growing development in the field of biotechnology due to rising healthcare needs and increasing investment by the government is again driving the market growth. Additionally, the growing demand for personalized medicines coupled with the penetration of new players and start-ups across developing economies is also projected to foster market growth. Furthermore, the increasing prevalence of chronic disease is further projected to propel the growth of the digital genome market. Read more @ https://coherentmarketinsights-blog.blogspot.com/2021/01/digital-genome-powerful-tool-for.html

Alkaline proteases are a type of enzyme that is active from neutral to pH range. An enzyme is any living thing that can be defined as a chemical reaction that changes something else, usually making a change in its shape or composition at some point during the catalytic reaction. The catalytic reaction may be a kinetic one - that is, it changes something because of the energy produced - or it may be a metabolic one - that is, it changes something because of the energy available for the catalytic reaction. Basically, an enzyme performs a number of functions: breaking down complex molecules into simple substances, assembling amino acids into peptide chains, playing a role in metabolism, and so on. The expanding biotechnology industry due to technological advancement is driving the growth of alkaline proteases market. The rise in the investment in research &development activities is again expected to augment market growth. High demand for proteases from the soaps & detergents industry is also projected to foster the market growth of alkaline proteases. Growing hygiene awareness and increasing demand for the food industry for the preparation of food products is also projected to propel the market growth. Furthermore, the growing demand for environmentally friendly products across emerging economies and increasing use of proteases as therapeutic agents is further projected to augment the growth of alkaline proteases market. Read more @ https://coherentmarketinsights-blog.blogspot.com/2021/01/advancement-in-biotechnology-sector-has.html

Stem cell banking is the process of collecting, processing, and storing potentially life-saving stem cells for future use. Stem cells have the potential to recreate and preserve the body, with their ability to develop into many different types of blood and tissue cell. Stem cell therapies can be used to treat diseases and repair organs and damaged tissues. Currently, cord blood stem cells can be used in transplants and therapies to treat more than 85 diseases, such as anemia, lymphomas, bone marrow cancer, and leukemia. With stem cell banking services gaining traction, adult stem cell preservation has been one of the fastest-growing areas of stem cell research. Stem cell preservation is the process of preserving stem cells that can be used for future treatments. The demand for stem cell preservation is increasing every day and is a wise investment for future medical needs. Moreover, stem cells can be used for the treatment of several life-threatening diseases, such as cancer, diabetes, and other chronic conditions. Stem cell banking offers the hope of turning these negatives into positives and helping stem cells to be effective and successful for future use. Read more @ https://coherentmarketinsights-cmi.blogspot.com/2020/12/banking-stem-cells-is-good-idea-as-they.html

ePharmacy as we know it today, provides pharmacy services to its customers through the use of the Internet. This technology has been around for quite some time but it wasn't until sometime ago that it started to gain popularity and slowly started replacing the traditional pharmacy. One of the advantages of using e-pharmacy over the traditional type of pharmacy is that there is no face to face interaction required between the customer and the pharmacists. Increasing adoption of smartphones is expected to propel growth of the ePharmacy market. For instance, according to Pew Research Center, 76% of adults in the U.K. owned a smartphone in 2018. Increasing geriatric population is expected to offer lucrative growth opportunities for players in the ePharmacy market. For instance, according to United Nations Population Fund, geriatric population in Asia Pacific is expected to triple between 2010 and 2050 to reach 1.3 billion people by 2050. Moreover, increasing investment in e-pharmacy is also expected to aid in growth of the market. For instance, in November 2020, Alodokter, an Indonesian telemedicine app, raised an undisclosed amount of funding from MDI Ventures, the corporate VC arm of Telkom Indonesia, in order to launch e-pharmacy. Read more @ https://coherentmarketinsights-blog.blogspot.com/2021/01/increasing-adoption-of-smartphones-and.html

A biologic drug (biologics) is a product that is produced from living organisms or contains components of living organisms. Biologic drugs are widely used to prevent, diagnose, treat, or cure a variety of diseases, including infectious diseases, autoimmune disorders, chronic kidney disease, and cancer. Biologics drugs are derived from a wide variety of natural sources such as human, animal, or microorganisms by using biotechnology. Moreover, Biologics include a wide variety of products such as blood and blood components, vaccines, tissues, allergenic, gene therapy, somatic cells, and recombinant therapeutic proteins. Novel therapies and new technologies are emerging to create new biologics, which holds a prominent future for the biologics market. The market is majorly driven by the increasing prevalence of chronic diseases across the globe, growing capital investment by key players, and higher acceptability and increasing demand for innovative therapies. For instance, according to the National Health Council, around 157 million Americans are expected to have more than one chronic disorder by 2020. Moreover, according to the World Health Organization, diabetes, cancer, and cardiovascular diseases account for around 1.6 million, 9 million, and 17.9 million deaths each year, respectively. Read more @ https://coherentmarketinsights-blog.blogspot.com/2020/11/increasing-prevalence-of-chronic.html

Myelofibrosis Treatment includes medications and surgery. There are drugs and medicines which are used to cure myelofibrosis. Myelofibrosis is a muscle disease and various types of myelofibrosis treatment are available in the market to cure this condition. The muscle disease is caused due to myelodysplasia, a genetically determined trait that prevents the muscle from growing properly. Myelofibrosis is also known as spider veins, lying in regions close to the skin, like the armpits, groin, elbows, and knees. Myelofibrosis is the most common type of connective tissue disease. These medicines are generally used to control and stop the progress of the disease, after which, they suppress the activity of the immune system. Various types of steroids are used as medicines for myelofibrosis, to control the activity of the immune system and thereby stop the disease in its tracks. One of the most common drugs for myelofibrosis treatment is prednisone, which is generally used along with steroids. However, to treat spider veins and not myelofibrosis, a compound called Finasteride is used. The most important part of myelofibrosis treatment is a regular check-up, as early as 18 months of the disease a doctor can monitor the progress of the disease. Myelofibrosis treatment also includes physical therapy and other treatments to improve the symptoms of myelofibrosis. The main driving factor influencing the growth of the myelofibrosis treatment market is the increasing prevalence of myelofibrosis in emerging economies. For instance, according to Gleneagles Global Hospitals, the yearly incidence rate of myelofibrosis in India is 0.3 to 1.5 cases per 100,000 individuals. Most of the times these cases goes unnoticed since it is sometimes asymptomatic or less severe. Moreover, the market is estimated to grow owing to a large number of R&D investments, a large cluster of patients suffering from myelofibrosis, and better reimbursement policies. Read more @ https://coherentmarketinsights-bl

Rise in prevalence and incidences of neurological disorders along with increased cost pressures of pharmaceutical drugs are anticipated to drive the electroceuticals market in the coming future. Moreover, rise in geriatric population and increase in investments for development of electroceuticals are expected to further boost the electroceuticals medicine market growth.